<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-DV0RBQ60</identifier><date>2021</date><creator>Więckowski, Zbigniew</creator><relation>documents/doc/D/URN_NBN_SI_doc-DV0RBQ60_001.pdf</relation><relation>documents/doc/D/URN_NBN_SI_doc-DV0RBQ60_001.txt</relation><format format_type="volume">14</format><format format_type="issue">2</format><format format_type="type">article</format><format format_type="extent">str. 479-493</format><identifier identifier_type="DOI">10.18690/mls.14.2.461-498.2021</identifier><identifier identifier_type="ISSN">2463-7955</identifier><identifier identifier_type="COBISSID">92929027</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-DV0RBQ60</identifier><language>eng</language><publisher publisher_location="Maribor">Pravna fakulteta</publisher><source>Medicine, law &amp; society</source><rights>InC</rights><subject language_type_id="slv">biološka zdravila</subject><subject language_type_id="slv">farmacija</subject><subject language_type_id="slv">medicina</subject><subject language_type_id="slv">pravo</subject><subject language_type_id="slv">redke bolezni</subject><subject language_type_id="slv">zakonodaja</subject><title>International cooperation as a prerequisite for improvement of access to orphan biologic medicines</title></Record>